Atlas Trials

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

Clinical trial NCT01258062 · COMPLETED

Trial details

NCT number
NCT01258062
Sponsor
Alachua Government Services, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
Start date
2010-09-01
Primary completion
2011-04-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.